Home » Topics » BioWorld Science

BioWorld Science
RSS

Heme oxygenase-1-modified exosomes developed for temozolomide-resistant glioblastoma

June 7, 2022

TPI1 as a novel therapeutic target in breast cancer

June 7, 2022

New Bruton tyrosine kinase inhibitors identified at Biogen

June 7, 2022

Neuron23 divulges LRRK2/NUAK1/TYK2 inhibitors

June 7, 2022

New cytokine inhibitors patented by Peptinov SAS, Conservatoire National des Arts et Metiers

June 7, 2022

New HSD17B13 inhibitors discovered at Inipharm

June 7, 2022

Genentech describes von Hippel-Lindau disease tumor suppressor inhibitors

June 7, 2022

LIPA targeting with ERX-41 shown useful to treat TNBC

June 7, 2022

Janux Therapeutics' JANX-007 to advance into clinical development

June 3, 2022

Nitrase Therapeutics announces expansion of pipeline to include oncology programs

June 3, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...